USA |NASDAQ |USD
| Report Date | Period Ending | EPS Forecast | Last Quarter's EPS | Last Year's EPS |
|---|---|---|---|---|
| Feb 23, 2022 | Dec 2021 | $-0.18 | - | $-0.08 |
| Report Date | Period Ending | Revenue Forecast | Last Quarter’s Revenue | Last Year’s Revenue |
|---|---|---|---|---|
| Feb 23, 2022 | Dec 2021 | $30.00K | - | $119.25K |
Cardiff Oncology's next earnings date is Wednesday, Feb 23, 2022 for the fiscal quarter ending Dec 2021.
| Period End | # of Analysts | EPS Forecast | Low EPS Forecast | High EPS Forecast |
|---|
| Period End | # of Analysts | EPS Forecast | Low EPS Forecast | High EPS Forecast |
|---|---|---|---|---|
| Dec 2022 | 4 | $-0.92 | $-1.15 | $-0.68 |
| Period End | Up/Down 1M | 1M Trend | 2M Trend | 3M Trend |
|---|
| Period End | Up/Down 1M | 1M Trend | 2M Trend | 3M Trend |
|---|---|---|---|---|
| Dec 2022 | 0 / 0 | $-0.92 | $-0.92 | $-1.01 |
| Period End | # of Analysts | Revenue Forecast | Low Revenue Forecast | High Revenue Forecast |
|---|
| Period End | # of Analysts | EPS Forecast | Low EPS Forecast | High EPS Forecast |
|---|---|---|---|---|
| Dec 2022 | 4 | $150.00K | $0.00 | $400.00K |
| Report Date | Period Ending | Forecast EPS | Actual EPS | Surprise |
|---|---|---|---|---|
| Nov 3, 2021 | Sep 2021 | $-0.17 | - | - |
| Aug 5, 2021 | Jun 2021 | $-0.15 | $-0.17 | -13.33% |
| May 6, 2021 | Mar 2021 | $-0.15 | $-0.14 | 5.08% |
| Feb 25, 2021 | Dec 2020 | $-0.14 | $-0.08 | 42.86% |
| Nov 5, 2020 | Sep 2020 | $-0.19 | $-0.19 | -1.77% |
| Aug 11, 2020 | Jun 2020 | $-0.24 | $-0.51 | -112.50% |
| May 7, 2020 | Mar 2020 | - | $-0.41 | - |
| Feb 27, 2020 | Dec 2019 | $-0.65 | $-0.51 | 21.54% |
| Nov 7, 2019 | Sep 2019 | $-0.84 | $-0.71 | 15.48% |
| Aug 8, 2019 | Jun 2019 | $-1.02 | $-0.79 | 22.55% |
| May 7, 2019 | Mar 2019 | $-1.07 | $-1.02 | 4.67% |
| Mar 6, 2019 | Dec 2018 | $-0.65 | $-1.09 | -67.69% |
| Nov 7, 2018 | Sep 2018 | $-1.98 | $-1.08 | 45.45% |
| Aug 3, 2018 | Jun 2018 | $-1.98 | $-2.76 | -39.39% |
| May 8, 2018 | Mar 2018 | $-5.76 | $-6.48 | -12.50% |
| Feb 26, 2018 | Dec 2017 | $-9.36 | $-4.32 | 53.85% |
| Nov 9, 2017 | Sep 2017 | $-10.08 | $-8.64 | 14.29% |
| Aug 9, 2017 | Jun 2017 | $-10.80 | $-18.72 | -73.33% |
| May 10, 2017 | Mar 2017 | $-17.28 | $-23.04 | -33.33% |
| Mar 15, 2017 | Dec 2016 | $-23.04 | $-20.16 | 12.50% |
| Nov 9, 2016 | Sep 2016 | $-23.76 | $-24.48 | -3.03% |
| Aug 4, 2016 | Jun 2016 | $-24.24 | $-24.48 | -0.99% |
| May 10, 2016 | Mar 2016 | $-23.40 | $-25.20 | -7.69% |
| Mar 10, 2016 | Dec 2015 | $-22.32 | $-18.72 | 16.13% |
| Nov 9, 2015 | Sep 2015 | $-0.27 | $-0.10 | 62.96% |
| Aug 10, 2015 | Jun 2015 | $-0.24 | $-0.41 | -70.83% |
| May 5, 2015 | Mar 2015 | $-0.24 | $-0.33 | -37.50% |
| Mar 12, 2015 | Dec 2014 | $-0.25 | $-0.25 | - |
| Nov 6, 2014 | Sep 2014 | $-0.24 | $-0.28 | -16.67% |
| Aug 7, 2014 | Jun 2014 | $-14.88 | $-4.32 | 70.97% |
| May 12, 2014 | Mar 2014 | $-14.04 | $-12.24 | 12.82% |
| Mar 17, 2014 | Dec 2013 | $-13.68 | $-3.60 | 73.68% |
| Nov 14, 2013 | Sep 2013 | $-16.20 | $-18.00 | -11.11% |
| Aug 14, 2013 | Jun 2013 | $-10.44 | $-10.80 | -3.45% |
| Apr 1, 2013 | Mar 2013 | $-6.12 | $-7.20 | -17.65% |
| Mar 31, 2013 | Dec 2012 | $-6.12 | $-7.20 | -17.65% |
| Nov 28, 2012 | Sep 2012 | - | $-3.35 | - |
| Aug 29, 2012 | Jun 2012 | - | $-20.47 | - |
| Mar 31, 2012 | Mar 2012 | - | $-7.67 | - |
| Dec 31, 2011 | Dec 2011 | - | $-9.32 | - |
| Sep 30, 2011 | Sep 2011 | - | $-0.00 | - |
| Jun 30, 2011 | Jun 2011 | - | $-4.12 | - |
| Mar 31, 2011 | Mar 2011 | - | $-3.94 | - |
| Jun 30, 2010 | Jun 2010 | - | $-6.21 | - |
| Mar 31, 2010 | Mar 2010 | - | $-4.44 | - |
| Report Date | Period Ending | Forecast EPS | Actual EPS | Surprise |
|---|---|---|---|---|
| Feb 25, 2021 | Dec 2020 | $-1.09 | $-1.19 | - |
| Feb 27, 2020 | Dec 2019 | - | $-3.03 | - |
| Mar 6, 2019 | Dec 2018 | - | $-11.41 | - |
| Feb 26, 2018 | Dec 2017 | - | $-54.72 | - |
| Mar 15, 2017 | Dec 2016 | - | $-94.32 | - |
| Mar 10, 2016 | Dec 2015 | - | $-19.56 | - |
| Mar 12, 2015 | Dec 2014 | - | $-17.09 | - |
| Mar 17, 2014 | Dec 2013 | - | $-39.60 | - |
| Mar 31, 2013 | Dec 2012 | - | $-38.69 | - |
| Dec 31, 2011 | Dec 2011 | - | $-28.02 | - |
| Report Date | Period Ending | Forecast Revenue | Actual Revenue | Surprise |
|---|---|---|---|---|
| Nov 3, 2021 | Sep 2021 | $30.00K | - | - |
| Aug 5, 2021 | Jun 2021 | $150.00K | $68.00K | 0.45% |
| May 6, 2021 | Mar 2021 | $150.00K | $72.00K | 0.48% |
| Feb 25, 2021 | Dec 2020 | $0.00 | $119.25K | - |
| Nov 5, 2020 | Sep 2020 | $30.00K | $136.40K | 4.55% |
| Aug 11, 2020 | Jun 2020 | $0.00 | $42.63K | - |
| May 7, 2020 | Mar 2020 | $0.00 | $67.70K | - |
| Feb 27, 2020 | Dec 2019 | - | $92.58K | - |
| Nov 7, 2019 | Sep 2019 | - | $51.69K | - |
| Aug 8, 2019 | Jun 2019 | - | $138.28K | - |
| May 7, 2019 | Mar 2019 | - | $161.96K | - |
| Mar 6, 2019 | Dec 2018 | - | $78.02K | - |
| Nov 7, 2018 | Sep 2018 | - | $88.36K | - |
| Aug 3, 2018 | Jun 2018 | - | $111.81K | - |
| May 8, 2018 | Mar 2018 | - | $100.14K | - |
| Feb 26, 2018 | Dec 2017 | - | $185.03K | - |
| Nov 9, 2017 | Sep 2017 | - | $123.33K | - |
| Aug 9, 2017 | Jun 2017 | - | $102.01K | - |
| May 10, 2017 | Mar 2017 | - | $95.04K | - |
| Mar 15, 2017 | Dec 2016 | - | $68.07K | - |
| Nov 9, 2016 | Sep 2016 | - | $89.11K | - |
| Aug 4, 2016 | Jun 2016 | - | $103.40K | - |
| May 10, 2016 | Mar 2016 | - | $120.49K | - |
| Mar 10, 2016 | Dec 2015 | - | $79.17K | - |
| Nov 9, 2015 | Sep 2015 | - | $57.33K | - |
| Aug 10, 2015 | Jun 2015 | - | $49.35K | - |
| May 5, 2015 | Mar 2015 | - | $126.97K | - |
| Mar 12, 2015 | Dec 2014 | - | $56.40K | - |
| Nov 6, 2014 | Sep 2014 | - | $57.20K | - |
| Aug 7, 2014 | Jun 2014 | - | $55.63K | - |
| May 12, 2014 | Mar 2014 | - | $110.95K | - |
| Mar 17, 2014 | Dec 2013 | - | $47.37K | - |
| Nov 14, 2013 | Sep 2013 | - | $43.76K | - |
| Aug 14, 2013 | Jun 2013 | - | $49.00K | - |
| Apr 1, 2013 | Mar 2013 | - | $119.12K | - |
| Mar 31, 2013 | Dec 2012 | - | $163.25K | - |
| Nov 28, 2012 | Sep 2012 | - | $211.50K | - |
| Aug 29, 2012 | Jun 2012 | - | $41.50K | - |
| Mar 31, 2012 | Mar 2012 | - | $34.15K | - |
| Dec 31, 2011 | Dec 2011 | - | $33.75K | - |
| Sep 30, 2011 | Sep 2011 | - | $55.00K | - |
| Jun 30, 2011 | Jun 2011 | - | $79.86K | - |
| Mar 31, 2011 | Mar 2011 | - | $89.08K | - |
| Jun 30, 2010 | Jun 2010 | - | $20.00K | - |
| Mar 31, 2010 | Mar 2010 | - | - | - |
| Report Date | Period Ending | Forecast Revenue | Actual Revenue | Surprise |
|---|---|---|---|---|
| Feb 25, 2021 | Dec 2020 | $366.00K | $365.99K | -0.00% |
| Feb 27, 2020 | Dec 2019 | - | $244.63K | - |
| Mar 6, 2019 | Dec 2018 | - | $378.32K | - |
| Feb 26, 2018 | Dec 2017 | - | $505.40K | - |
| Mar 15, 2017 | Dec 2016 | - | $381.07K | - |
| Mar 10, 2016 | Dec 2015 | - | $312.81K | - |
| Mar 12, 2015 | Dec 2014 | - | $280.18K | - |
| Mar 17, 2014 | Dec 2013 | - | $259.25K | - |
| Mar 31, 2013 | Dec 2012 | - | $450.40K | - |
| Dec 31, 2011 | Dec 2011 | - | $257.70K | - |
CRDF's next earnings date is Wednesday, Feb 23, 2022 for the fiscal quarter ending Dec 31, 2021.
According to analysts, the average EPS estimation for Cardiff Oncology's next quarterly earnings is $-0.18, with a low EPS estimation of $-0.20, and a high estimation of $-0.16.
Over the last 1 month, EPS estimates have seen 0 upward revisions and 0 downward. The EPS 1 month trend is $-0.18, the last 2 month trend is $-0.18, and the 3 month trend is $-0.18.
Based on analysts, the average revenue estimation is $30.00K, with a low revenue estimation of $0.00, and a high estimation of $70.00K.
Cardiff Oncology's previous earnings date was Nov 3, 2021 for its fiscal quarter ended Sep 30, 2021.
Cardiff Oncology's previous annual earnings date was Feb 25, 2021 for its fiscal year ended Dec 31, 2020.
CRDF's earnings per share (EPS) was $-1.19, missing the consensus analysts forecast of $-1.09 by 9.17% , and higher than the previous year's EPS (Dec 2019) by -60.73%.
Revenues were $365.99K, worse than the forecast of $366.00K by -0.00%, and up by 49.61% from previous year's revenue.
The company reported a net income of $-19.31M.
Cardiff Oncology reported a free cash flow of $-16.53M for its fiscal year, compared to $-13.34M a year ago.
The company ended the fiscal year with $869.50K in total debt, a decrease of -49.63% compared to the previous year.
Get a weekly snapshot of one new investment idea from stock exchanges worldwide.
